Viewing Study NCT00912392


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2025-12-24 @ 3:17 PM
Study NCT ID: NCT00912392
Status: COMPLETED
Last Update Posted: 2014-09-03
First Post: 2009-06-01
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Sponsor: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-05
Start Date Type: None
Primary Completion Date: 2012-12
Primary Completion Date Type: ACTUAL
Completion Date: 2012-12
Completion Date Type: ACTUAL
First Submit Date: 2009-06-01
First Submit QC Date: None
Study First Post Date: 2009-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-08-31
Last Update Post Date: 2014-09-03
Last Update Post Date Type: ESTIMATED